Cardinal Health, eMed distribute at-home COVID-19 tests to thousands of pharmacies
Digital health company eMed and Cardinal Health are partnering to distribute millions of the Abbott BinaxNow at-home COVID-19 rapid test to pharmacies across the continental United States, Puerto Rico and U.S. Virgin Islands.
“There is a significant need for affordable, easily accessible coronavirus testing in this country now and in the future,” said Patrice Harris, eMed CEO. “This collaboration with Cardinal Health puts us closer to consumers, providing them with pick-up options at convenient pharmacy locations they frequent, know and trust.”
eMed offers a digital health platform that enables an eMed guide to virtually walk individuals through the testing process. The tests require no additional equipment, are authenticated, and deliver results within minutes, the company said.
Under the agreement with Cardinal Health, the eMed tests will be distributed to pharmacies nationwide and be available for consumer pickup. Users will complete a questionnaire form at eMed.com, then present the completed form at a participating pharmacy to be evaluated by a pharmacist. Following their consultation with a pharmacist, they receive a test for at-home administration if eligible.
Besides guiding patients through the test, the eMed guide also will authenticate the test and result, automatically reporting to public health departments for tracking and tracing.
“This collaboration will enable all pharmacies nationwide to offer convenient, at-home tests to their patients, and help protect against the further spread of COVID-19 in their communities,” said Victor Crawford, Cardinal Health pharmaceutical segment CEO. “We are pleased to work together with eMed and use our preeminent distribution network to ensure these tests can be easily accessed by all pharmacies in the continental United States, Puerto Rico and U.S. Virgin Islands to fight the pandemic.”
Between the collaboration with Cardinal Health, individual sales, and partnerships with state governments, businesses and organizations, eMed plans to distribute and administer millions of tests throughout the country.